Límite 04 Ago 2021
Oferta Empresarial
Ref.
BOKR20200706001
A leading biotech Korean company specialized in producing high-quality diagnostic kit for COVID-19 seeks for global partners
The Korean company specializing in multiplex molecular diagnostics with the aim of completing localization of genetic technology is offering a COVID-19 diagnostic kit. The kit is based on real-time PCR method which features high sensitivity and accuracy. Also, this kit detects 3 targets per tube which make more efficient diagnosis available. It takes only 1 hour 30 minuntes for Real-Time PCR and is compatible with 4 types of Real-Time PCR machines.